Back to search

Article

Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination

2023-04-06

Abstract excerpt

<title>Abstract</title> <p>Although young children generally experience mild symptoms following infection with SARS-CoV-2, severe acute and long-term complications can occur. SARS-CoV-2 mRNA vaccines elicit robust immunoglobulin profiles in children ages 5 years and older, and in adults, corresponding with substantial protection against hospitalizations and severe disease. Whether similar immune responses and hum...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1510902b-98a8-5f88-9d03-daff1facef6f
DOI
10.21203/rs.3.rs-2748734/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccinationDOI 10.21203/rs.3.rs-2748734/v1
Comprehensive antibody profiling of mRNA vaccination in childrenSemantic proximity
Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adultsSemantic proximity
mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concernSemantic proximity
Determinants of early antibody responses to COVID-19 mRNA vaccines in exposed and naive healthcare workersSemantic proximity
Infant CD4 T-cell response to SARS-CoV-2 mRNA vaccination is restricted in cytokine production and modified by vaccine manufacturerSemantic proximity
Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic reviewSemantic proximity
Reactogenicity, Safety, and Serological and Cellular Immunogenicity of a Booster Dose of SARS-CoV-2 mRNA Prototype, Variant, and Bivalent VaccinesSemantic proximity
Preserved T-Cell Immunity Despite Impaired Humoral Responses following SARS-CoV-2 Infection and Vaccination in Children with Profound B-cell LymphopeniaSemantic proximity
Inactivated vaccine fueled adaptive immune responses to Omicron in 2-year COVID-19 convalescentsSemantic proximity
Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals.Semantic proximity
Resilient Fc-Effector Functions Across SARS-CoV-2 Variants of Concern Following mRNA-1273 VaccinationSemantic proximity
Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA VaccinationSemantic proximity
Select a neighboring publication to make it the new centre.